Investors Seek Justice: Class Action Filed Against Applied Therapeutics

LOS ANGELES, Feb. 13, 2025 /PRNewswire/ — Glancy Prongay & Murray LLP has announced that investors who have suffered losses now have the chance to lead a securities fraud class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) APLT.

Deadline Alert for Investors: Click Here Before FEBRUARY 18, 2025
If you experienced a loss on your investments in Applied Therapeutics, this is your chance to take action and participate in the securities fraud lawsuit.

Details of the Lawsuit
The complaint, filed by Glancy Prongay & Murray LLP, alleges that from January 3, 2024 to December 2, 2024, the defendants failed to inform investors of significant risks. They did not adhere to trial protocols or good clinical practices, which posed a serious risk that the FDA would reject their trial data when it came time for New Drug Application (NDA) approval. Consequently, the defendants’ positive remarks about Applied Therapeutics’ operations and future prospects were likely misleading.

Get In Touch to Participate or Learn More:
If you want to learn more about this lawsuit or have questions regarding your rights in this matter, feel free to reach out.

Charles Linehan, Esq.,
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100,
Los Angeles, California 90067
Email:  [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit us at www.glancylaw.com.
Stay updated on LinkedIn, Twitter, or Facebook.

For inquiries via email, please include your mailing address, phone number, and the number of shares you purchased.

To join the class action, no immediate action is required; you may choose to retain an attorney or remain an absent member of the class.

This press release could be viewed as Attorney Advertising in certain jurisdictions according to local laws and ethical standards.

Contact Information:
Glancy Prongay & Murray LLP, 
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email:  [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

View original content to download multimedia: https://www.prnewswire.com/news-releases/applied-therapeutics-inc-aplt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302375976.html

SOURCE Glancy Prongay & Murray LLP